Article
Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
FEBS letters - 11 Oct 2013
Cheng Shan, Li Yang, Yang Ying, Feng Duiping, Yang Longyan, Ma Qian, Zheng Shuai, Meng Ran, Wang Shuhui, Wang Songlin, Jiang Wen G, He Junqi
Abstract excerpt
Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is a scaffold protein known to interact with a number of cancer-related proteins. nherf1 Mutations (K172N and D301V) were recently identified in breast cancer cells. To investigate the functional properties of NHERF1, wild-type and cancer-derived nherf1 mutations were stably expressed in SKMES-1 cells respectively. NHERF1-wt overexpression suppressed the cellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
